下呼吸道感染运用哌拉西林/他唑巴坦的临床疗效评价

Clinical evaluation of the use of Piperacillin/Tazobactam in lower respiratory tract infection

目的:探讨哌拉西林/他唑巴坦治疗下呼吸道感染的临床疗效。方法:选取80例我院治疗的下呼吸道感染患者随机分成对照组和治疗组,每组40例,对照组给予哌拉西林/舒巴坦治疗,治疗组给予哌拉西林/他唑巴坦。结果:随访观察显示治疗组和对照组的有效率分别为85.00%和67.50%,两组有效率比较,差异有统计学意义(P<0.05),哌拉西林/他唑巴坦组临床疗效更好。结论:哌拉西林/他唑巴坦治疗下呼吸道感染的疗效好、不良反应少,可在临床推广。

Objective： To investigate the clinical efficacy of Piperacillin/Tazobactam in treatment of lower respiratory tract infection. Methods： 80 cases of lower respiratory tract infection patients were divided into two groups with 40 cases in each group. Piperacillin/Sulbactam was given tQ control group and Piperacillin/Tazobactam was given to treatment group. Results： The effective rates in the treatment group and control group were respectively 85.00% and 67.50%, and difference between the two groups was significant （P〈0.05）. Piperacillin/Tazobaetam group had the better clinical efficacy. Conclu- sion： Clinical efficacy of Piperacillin/Tazobactam used in lower respiratory tract infection patients is better. It has lower adverse reactions, and should be popularize in clinic.